| scholarly article | Q13442814 |
| P50 | author | Ivana Jovčevska | Q87479318 |
| Alja Videtič Paska | Q88107120 | ||
| P2093 | author name string | Alja Zottel | |
| P2860 | cites work | Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism | Q24594703 |
| Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential | Q24657256 | ||
| Nanobodies as Versatile Tools to Understand, Diagnose, Visualize and Treat Cancer | Q26739702 | ||
| Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy | Q26745710 | ||
| Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases | Q26747148 | ||
| Tweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targeting | Q26785347 | ||
| Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes | Q26825792 | ||
| Nanotechnology in cancer therapy | Q27023013 | ||
| Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier. | Q28082016 | ||
| Crossing the blood-brain barrier with nanoparticles | Q47900736 | ||
| Role of extracellular vesicles in glioma progression | Q47925638 | ||
| An overview on the current status of cancer nanomedicines. | Q48349126 | ||
| A prodrug nanoparticle approach for the oral delivery of a hydrophilic peptide, leucine(5)-enkephalin, to the brain | Q48520766 | ||
| Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models. | Q48600293 | ||
| Progress in Nanomedicine: Approved and Investigational Nanodrugs | Q49188363 | ||
| Glioma-Targeted Delivery of a Theranostic Liposome Integrated with Quantum Dots, Superparamagnetic Iron Oxide, and Cilengitide for Dual-Imaging Guiding Cancer Surgery | Q49923399 | ||
| Recent progress in dendrimer-based nanomedicine development. | Q49946701 | ||
| Shedding light on the cell biology of extracellular vesicles | Q50018560 | ||
| Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization | Q90675224 | ||
| Cell-penetrating Peptide-coated Liposomes for Drug Delivery Across the Blood-Brain Barrier | Q90784206 | ||
| Legal and practical challenges in classifying nanomaterials according to regulatory definitions | Q92150358 | ||
| Natural biodegradable polymers based nano-formulations for drug delivery: A review | Q92240967 | ||
| Liposome-based probes for molecular imaging: from basic research to the bedside | Q92474128 | ||
| Nanobodies and Cancer: Current Status and New Perspectives | Q52586587 | ||
| Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood–brain barrier in vitro and their influence on barrier integrity | Q52607718 | ||
| Magnetic nanoparticles in cancer therapy: how can thermal approaches help? | Q54096352 | ||
| Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targeting. | Q54965858 | ||
| Current state of immunotherapy for glioblastoma | Q55457323 | ||
| Traceable Nanoparticles with Dual Targeting and ROS Response for RNAi-Based Immunochemotherapy of Intracranial Glioblastoma Treatment | Q55457400 | ||
| Role of nanobiotechnology in the personalized management of glioblastoma multiforme | Q55463119 | ||
| Enhanced Oral Absorption of Hydrophobic and Hydrophilic Drugs Using Quaternary Ammonium Palmitoyl Glycol Chitosan Nanoparticles | Q57610428 | ||
| Cutting Edge Therapeutic Insights Derived from Molecular Biology of Pediatric High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG) | Q57811969 | ||
| Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment | Q58591620 | ||
| Tumor Microenvironment Targeted Nanotherapy | Q59133567 | ||
| Impact of Nanoparticles on Brain Health: An Up to Date Overview | Q60935443 | ||
| Blood-Brain Delivery Methods Using Nanotechnology | Q60960607 | ||
| Exosomes in cancer: Use them or target them? | Q61637649 | ||
| Current Trends in Cancer Nanotheranostics: Metallic, Polymeric, and Lipid-Based Systems | Q61803672 | ||
| Superparamagnetic Iron Oxide Nanoparticles-Current and Prospective Medical Applications | Q64263981 | ||
| Embryonic Stem Cells-Derived Exosomes Endowed with Targeting Properties as Chemotherapeutics Delivery Vehicles for Glioblastoma Therapy | Q64271846 | ||
| The Role of Nanobiotechnology in the Development of Personalized Medicine | Q82899705 | ||
| Role of nanobiotechnology in the development of personalized medicine | Q83580657 | ||
| Nanodiagnostics: leaving the research lab to enter the clinics? | Q88057154 | ||
| Perspectives of Nanotechnology in the Management of Gliomas | Q89501346 | ||
| Nanoparticle crossing of blood-brain barrier: a road to new therapeutic approaches to central nervous system diseases | Q89586089 | ||
| Prediction of Anti-cancer Nanotherapy Efficacy by Imaging | Q89736571 | ||
| Effect of metformin/irinotecan-loaded poly-lactic-co-glycolic acid nanoparticles on glioblastoma: in vitro and in vivo studies | Q90361156 | ||
| Recent Advances of Gold Nanoparticles in Biomedical Applications: State of the Art | Q90664352 | ||
| Arginine modified PAMAM dendrimer for interferon beta gene delivery to malignant glioma | Q39199004 | ||
| Nanomaterial-Enabled Cancer Therapy | Q39323096 | ||
| A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas | Q39390470 | ||
| Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases | Q39421915 | ||
| Platinum nanoparticles in nanobiomedicine. | Q39428343 | ||
| EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma | Q39677767 | ||
| Quantum dots in imaging, drug delivery and sensor applications. | Q41283510 | ||
| Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy. | Q41734074 | ||
| Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier | Q42153590 | ||
| Quantum dots-from synthesis to applications in biomedicine and life sciences | Q42917770 | ||
| Transport of nanoparticles through the blood-brain barrier for imaging and therapeutic applications | Q44696669 | ||
| Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo | Q46067245 | ||
| Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB). | Q46355807 | ||
| Cancer nanomedicine: a review of recent success in drug delivery | Q47102124 | ||
| The effect of nanoparticle size on the ability to cross the blood-brain barrier: an in vivo study | Q47205769 | ||
| Tumor Microenvironment-Enabled Nanotherapy. | Q47761233 | ||
| Liposomes as nanomedical devices | Q28088315 | ||
| Nanobodies: Natural Single-Domain Antibodies | Q28287268 | ||
| The bactericidal effect of silver nanoparticles | Q29615514 | ||
| Nanocarriers as an emerging platform for cancer therapy | Q29616699 | ||
| Recent advances with liposomes as pharmaceutical carriers | Q29616702 | ||
| Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes | Q29617554 | ||
| Advances in the field of nanooncology | Q30477604 | ||
| Nanobodies as novel agents for cancer therapy | Q30778309 | ||
| Quantum Dot-Based Nanotools for Bioimaging, Diagnostics, and Drug Delivery | Q31122176 | ||
| Near-infrared light-triggered theranostics for tumor-specific enhanced multimodal imaging and photothermal therapy | Q33825897 | ||
| Block copolymer micelles for drug delivery: design, characterization and biological significance | Q34184381 | ||
| Generation of Single Domain Antibody Fragments Derived from Camelids and Generation of Manifold Constructs | Q34386048 | ||
| TRIM28 and β-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkers | Q34566316 | ||
| Antimicrobial effects of silver nanoparticles. | Q34611349 | ||
| Nanoparticles in medicine: therapeutic applications and developments | Q34655287 | ||
| Blood-brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imaging | Q34714550 | ||
| Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood-brain tumor barrier. | Q34985892 | ||
| Nanodiagnostics: application of nanotechnology in molecular diagnostics | Q35089150 | ||
| Nanotechnology and medicine | Q35164817 | ||
| Intraoperative diagnostics and elimination of residual microtumours with plasmonic nanobubbles | Q35924002 | ||
| Polymers for Drug Delivery Systems | Q36225509 | ||
| Block copolymer micelles: preparation, characterization and application in drug delivery | Q36313576 | ||
| Therapeutic possibilities of plasmonically heated gold nanoparticles | Q36354450 | ||
| Nanotechnology for cancer diagnostics: promises and challenges | Q36481101 | ||
| Extracellular Vesicles: Composition, Biological Relevance, and Methods of Study | Q36647312 | ||
| Use of nanoparticles for drug delivery in glioblastoma multiforme | Q36787338 | ||
| Nanotechnology for targeted cancer therapy | Q36842770 | ||
| Tumour-targeted nanomedicines: principles and practice. | Q36858135 | ||
| Nanobiotechnology-based drug delivery to the central nervous system | Q36878897 | ||
| Magnetic nanoparticles and their applications in medicine | Q36917874 | ||
| Quantum dots and multifunctional nanoparticles: new contrast agents for tumor imaging | Q36917898 | ||
| Liposomal nanomedicines | Q37039021 | ||
| Recent advances in nanooncology | Q37058424 | ||
| Nanomedicine: application of nanobiotechnology in medical practice | Q37089590 | ||
| Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs | Q37141404 | ||
| Gold nanoparticles in delivery applications | Q37191739 | ||
| Multifunctional Quantum Dots for Personalized Medicine. | Q37377137 | ||
| Glioma virus therapies between bench and bedside | Q37580510 | ||
| Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer | Q37616813 | ||
| Role and implications of nanodiagnostics in the changing trends of clinical diagnosis | Q37618012 | ||
| Cancer Immunotherapy and Nanomedicine | Q37785836 | ||
| Nanomedicine. | Q37821004 | ||
| Nanobiotechnology and Personalized Medicine | Q37957326 | ||
| Gold Nanomaterials: Preparation, Chemical Modification, Biomedical Applications and Potential Risk Assessment | Q37978752 | ||
| Polymeric micelles drug delivery system in oncology. | Q37979580 | ||
| Role of Nanodiagnostics in Personalized Cancer Therapy | Q37984869 | ||
| Dendrimers in cancer therapeutics and diagnosis | Q37989497 | ||
| Molecular Biology of Glioma | Q38013704 | ||
| Nanobiotechnology-Based Strategies for Crossing The Blood–Brain Barrier | Q38038895 | ||
| Liposomal drug delivery systems: from concept to clinical applications | Q38049376 | ||
| Nanomedicines and nanodiagnostics come of age. | Q38061873 | ||
| Silicon quantum dots for biological applications | Q38129353 | ||
| Nanobodies as novel agents for disease diagnosis and therapy. | Q38160835 | ||
| Magnetic hyperthermia with magnetic nanoparticles: a status review | Q38180193 | ||
| Silver nanoparticles: synthesis, properties, and therapeutic applications | Q38301509 | ||
| Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications | Q38302247 | ||
| Nanobody-based cancer therapy of solid tumors | Q38322471 | ||
| Polybutylcyanoacrylate nanocarriers as promising targeted drug delivery systems | Q38367597 | ||
| Nef is secreted in exosomes from Nef.GFP-expressing and HIV-1-infected human astrocytes. | Q38648833 | ||
| Strategies for transporting nanoparticles across the blood-brain barrier | Q38662677 | ||
| Recent progress in theranostic applications of hybrid gold nanoparticles | Q38664056 | ||
| Silver nanoparticles: A new view on mechanistic aspects on antimicrobial activity | Q38685196 | ||
| Synthesis of tumor-targeted folate conjugated fluorescent magnetic albumin nanoparticles for enhanced intracellular dual-modal imaging into human brain tumor cells | Q38752008 | ||
| Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy? | Q38770717 | ||
| Nanobodies as therapeutics: big opportunities for small antibodies | Q38808711 | ||
| The evolving landscape of drug products containing nanomaterials in the United States | Q38823222 | ||
| Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery | Q38850073 | ||
| Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy | Q38850079 | ||
| Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date | Q38853466 | ||
| The emergent role of exosomes in glioma | Q38988293 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P921 | main subject | nanotechnology | Q11468 |
| nanomaterial | Q967847 | ||
| brain cancer | Q9303627 | ||
| P577 | publication date | 2019-05-15 | |
| P1433 | published in | Materials | Q6786584 |
| P1476 | title | Nanotechnology Meets Oncology: Nanomaterials in Brain Cancer Research, Diagnosis and Therapy | |
| P478 | volume | 12 |
| Q93108942 | A Novel Drug Design Strategy: An Inspiration from Encaging Tumor by Metallofullerenol Gd@C82(OH)22 |
| Q97523107 | Emerging treatment strategies for breast cancer brain metastasis: from translational therapeutics to real-world experience |
| Q90224099 | Hyaluronic Acid-Conjugated with Hyperbranched Chlorin e6 Using Disulfide Linkage and Its Nanophotosensitizer for Enhanced Photodynamic Therapy of Cancer Cells |
| Q93200295 | Magnetic Temperature-Sensitive Solid-Lipid Particles for Targeting and Killing Tumor Cells |
| Q91675856 | Theranostic Nanomedicine for Malignant Gliomas |
Search more.